Clinical Trials Logo

Citation(s)

  •   Mabilleau G, Gobron B, Bouvard B, Chappard D
    Incretin-based therapy for the treatment of bone fragility in diabetes mellitus. Peptides. 2018 Feb;100:108-113. doi: 10.1016/j.peptides.2017.12.008.
  •   Mabilleau G, Gobron B, Mieczkowska A, Perrot R, Chappard D
    Efficacy of targeting bone-specific GIP receptor in ovariectomy-induced bone loss. J Endocrinol. 2018 Aug 18:JOE-18-0214. doi: 10.1530/JOE-18-0214. Online ahead of print.
  •   Mabilleau G
    Interplay between bone and incretin hormones: A review. Morphologie. 2017 Mar;101(332):9-18. doi: 10.1016/j.morpho.2016.06.004. Epub 2016 Aug 8.

INcrétines et REModelage OSseux

Details for clinical trial NCT03966261